Cargando…

Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo

BACKGROUND: Ways to prevent disease-induced vascular modifications that accelerate brain damage remain largely elusive. Improved understanding of perivascular cell signalling could provide unparalleled insight as these cells impact vascular stability and functionality of the neurovascular unit as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumann, Julia, Tsao, Chih-Chieh, Patkar, Shalmali, Huang, Sheng-Fu, Francia, Simona, Magnussen, Synnøve Norvoll, Gassmann, Max, Vogel, Johannes, Köster-Hegmann, Christina, Ogunshola, Omolara O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760662/
https://www.ncbi.nlm.nih.gov/pubmed/35033138
http://dx.doi.org/10.1186/s12987-021-00302-y
_version_ 1784633369877807104
author Baumann, Julia
Tsao, Chih-Chieh
Patkar, Shalmali
Huang, Sheng-Fu
Francia, Simona
Magnussen, Synnøve Norvoll
Gassmann, Max
Vogel, Johannes
Köster-Hegmann, Christina
Ogunshola, Omolara O.
author_facet Baumann, Julia
Tsao, Chih-Chieh
Patkar, Shalmali
Huang, Sheng-Fu
Francia, Simona
Magnussen, Synnøve Norvoll
Gassmann, Max
Vogel, Johannes
Köster-Hegmann, Christina
Ogunshola, Omolara O.
author_sort Baumann, Julia
collection PubMed
description BACKGROUND: Ways to prevent disease-induced vascular modifications that accelerate brain damage remain largely elusive. Improved understanding of perivascular cell signalling could provide unparalleled insight as these cells impact vascular stability and functionality of the neurovascular unit as a whole. Identifying key drivers of astrocyte and pericyte responses that modify cell–cell interactions and crosstalk during injury is key. At the cellular level, injury-induced outcomes are closely entwined with activation of the hypoxia-inducible factor-1 (HIF-1) pathway. Studies clearly suggest that endothelial HIF-1 signalling increases blood–brain barrier permeability but the influence of perivascular HIF-1 induction on outcome is unknown. Using novel mouse lines with astrocyte and pericyte targeted HIF-1 loss of function, we herein show that vascular stability in vivo is differentially impacted by perivascular hypoxia-induced HIF-1 stabilization. METHODS: To facilitate HIF-1 deletion in adult mice without developmental complications, novel Cre-inducible astrocyte-targeted (GFAP-CreER(T2); HIF-1α(fl/fl) and GLAST-CreER(T2); HIF-1α(fl/fl)) and pericyte-targeted (SMMHC-CreER(T2); HIF-1α(fl/fl)) transgenic animals were generated. Mice in their home cages were exposed to either normoxia (21% O(2)) or hypoxia (8% O(2)) for 96 h in an oxygen-controlled humidified glove box. All lines were similarly responsive to hypoxic challenge and post-Cre activation showed significantly reduced HIF-1 target gene levels in the individual cells as predicted. RESULTS: Unexpectedly, hypoxia-induced vascular remodelling was unaffected by HIF-1 loss of function in the two astrocyte lines but effectively blocked in the pericyte line. In correlation, hypoxia-induced barrier permeability and water accumulation were abrogated only in pericyte targeted HIF-1 loss of function mice. In contrast to expectation, brain and serum levels of hypoxia-induced VEGF, TGF-β and MMPs (genes known to mediate vascular remodelling) were unaffected by HIF-1 deletion in all lines. However, in agreement with the permeability data, immunofluorescence and electron microscopy showed clear prevention of hypoxia-induced tight junction disruption in the pericyte loss of function line. CONCLUSION: This study shows that pericyte but not astrocyte HIF-1 stabilization modulates endothelial tight junction functionality and thereby plays a pivotal role in hypoxia-induced vascular dysfunction. Whether the cells respond similarly or differentially to other injury stimuli will be of significant relevance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-021-00302-y.
format Online
Article
Text
id pubmed-8760662
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87606622022-01-18 Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo Baumann, Julia Tsao, Chih-Chieh Patkar, Shalmali Huang, Sheng-Fu Francia, Simona Magnussen, Synnøve Norvoll Gassmann, Max Vogel, Johannes Köster-Hegmann, Christina Ogunshola, Omolara O. Fluids Barriers CNS Research BACKGROUND: Ways to prevent disease-induced vascular modifications that accelerate brain damage remain largely elusive. Improved understanding of perivascular cell signalling could provide unparalleled insight as these cells impact vascular stability and functionality of the neurovascular unit as a whole. Identifying key drivers of astrocyte and pericyte responses that modify cell–cell interactions and crosstalk during injury is key. At the cellular level, injury-induced outcomes are closely entwined with activation of the hypoxia-inducible factor-1 (HIF-1) pathway. Studies clearly suggest that endothelial HIF-1 signalling increases blood–brain barrier permeability but the influence of perivascular HIF-1 induction on outcome is unknown. Using novel mouse lines with astrocyte and pericyte targeted HIF-1 loss of function, we herein show that vascular stability in vivo is differentially impacted by perivascular hypoxia-induced HIF-1 stabilization. METHODS: To facilitate HIF-1 deletion in adult mice without developmental complications, novel Cre-inducible astrocyte-targeted (GFAP-CreER(T2); HIF-1α(fl/fl) and GLAST-CreER(T2); HIF-1α(fl/fl)) and pericyte-targeted (SMMHC-CreER(T2); HIF-1α(fl/fl)) transgenic animals were generated. Mice in their home cages were exposed to either normoxia (21% O(2)) or hypoxia (8% O(2)) for 96 h in an oxygen-controlled humidified glove box. All lines were similarly responsive to hypoxic challenge and post-Cre activation showed significantly reduced HIF-1 target gene levels in the individual cells as predicted. RESULTS: Unexpectedly, hypoxia-induced vascular remodelling was unaffected by HIF-1 loss of function in the two astrocyte lines but effectively blocked in the pericyte line. In correlation, hypoxia-induced barrier permeability and water accumulation were abrogated only in pericyte targeted HIF-1 loss of function mice. In contrast to expectation, brain and serum levels of hypoxia-induced VEGF, TGF-β and MMPs (genes known to mediate vascular remodelling) were unaffected by HIF-1 deletion in all lines. However, in agreement with the permeability data, immunofluorescence and electron microscopy showed clear prevention of hypoxia-induced tight junction disruption in the pericyte loss of function line. CONCLUSION: This study shows that pericyte but not astrocyte HIF-1 stabilization modulates endothelial tight junction functionality and thereby plays a pivotal role in hypoxia-induced vascular dysfunction. Whether the cells respond similarly or differentially to other injury stimuli will be of significant relevance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-021-00302-y. BioMed Central 2022-01-15 /pmc/articles/PMC8760662/ /pubmed/35033138 http://dx.doi.org/10.1186/s12987-021-00302-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Baumann, Julia
Tsao, Chih-Chieh
Patkar, Shalmali
Huang, Sheng-Fu
Francia, Simona
Magnussen, Synnøve Norvoll
Gassmann, Max
Vogel, Johannes
Köster-Hegmann, Christina
Ogunshola, Omolara O.
Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo
title Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo
title_full Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo
title_fullStr Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo
title_full_unstemmed Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo
title_short Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo
title_sort pericyte, but not astrocyte, hypoxia inducible factor-1 (hif-1) drives hypoxia-induced vascular permeability in vivo
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760662/
https://www.ncbi.nlm.nih.gov/pubmed/35033138
http://dx.doi.org/10.1186/s12987-021-00302-y
work_keys_str_mv AT baumannjulia pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo
AT tsaochihchieh pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo
AT patkarshalmali pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo
AT huangshengfu pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo
AT franciasimona pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo
AT magnussensynnøvenorvoll pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo
AT gassmannmax pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo
AT vogeljohannes pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo
AT kosterhegmannchristina pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo
AT ogunsholaomolarao pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo